ATE228312T1 - Antioxidative mischung bestehend aus acetyl l- carnitin und alpha-liponsäure - Google Patents

Antioxidative mischung bestehend aus acetyl l- carnitin und alpha-liponsäure

Info

Publication number
ATE228312T1
ATE228312T1 AT99939612T AT99939612T ATE228312T1 AT E228312 T1 ATE228312 T1 AT E228312T1 AT 99939612 T AT99939612 T AT 99939612T AT 99939612 T AT99939612 T AT 99939612T AT E228312 T1 ATE228312 T1 AT E228312T1
Authority
AT
Austria
Prior art keywords
carnitine
acetyl
alpha
mixture consisting
antioxidant mixture
Prior art date
Application number
AT99939612T
Other languages
English (en)
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11406116&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE228312(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Application granted granted Critical
Publication of ATE228312T1 publication Critical patent/ATE228312T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
AT99939612T 1998-09-01 1999-08-19 Antioxidative mischung bestehend aus acetyl l- carnitin und alpha-liponsäure ATE228312T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1998RM000566A IT1302307B1 (it) 1998-09-01 1998-09-01 Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil
PCT/IT1999/000268 WO2000011968A1 (en) 1998-09-01 1999-08-19 ANTIOXIDANT COMPOSITION COMPRISING ACETYL L-CARNITINE AND α-LIPOIC ACID

Publications (1)

Publication Number Publication Date
ATE228312T1 true ATE228312T1 (de) 2002-12-15

Family

ID=11406116

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99939612T ATE228312T1 (de) 1998-09-01 1999-08-19 Antioxidative mischung bestehend aus acetyl l- carnitin und alpha-liponsäure

Country Status (28)

Country Link
US (1) US6365622B1 (de)
EP (1) EP1112005B2 (de)
JP (1) JP4361215B2 (de)
KR (1) KR20010079699A (de)
CN (1) CN1315835A (de)
AR (1) AR022076A1 (de)
AT (1) ATE228312T1 (de)
AU (1) AU773424B2 (de)
BR (1) BR9913288A (de)
CA (1) CA2341973C (de)
CZ (1) CZ2001541A3 (de)
DE (1) DE69904208T3 (de)
DK (1) DK1112005T4 (de)
EE (1) EE200100113A (de)
ES (1) ES2188214T5 (de)
HK (1) HK1039730A1 (de)
HU (1) HU229165B1 (de)
IL (1) IL141435A0 (de)
IS (1) IS5850A (de)
IT (1) IT1302307B1 (de)
MA (1) MA25284A1 (de)
NO (1) NO20010954L (de)
PL (1) PL212737B1 (de)
PT (1) PT1112005E (de)
SK (1) SK2632001A3 (de)
TN (1) TNSN99163A1 (de)
TR (1) TR200100610T2 (de)
WO (1) WO2000011968A1 (de)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562869B1 (en) 1999-09-23 2003-05-13 Juvenon, Inc. Nutritional supplement for increased energy and stamina
US6479069B1 (en) 1999-09-23 2002-11-12 Juvenon, Inc. Nutritional supplement for increased energy and stamina
EP1248609A4 (de) * 1999-11-03 2007-08-01 Juvenon Inc Verfahren zur behandlung der gutartigen gedächtnissstörung
US6664287B2 (en) * 2000-03-15 2003-12-16 Bethesda Pharmaceuticals, Inc. Antioxidants
DE10036797A1 (de) * 2000-07-28 2002-02-07 Beiersdorf Ag Verwendung von Kombinationen mit einem Gehalt an Carnitinen
EP1339404A2 (de) * 2000-10-31 2003-09-03 Colgate-Palmolive Company Zusammensetzung und verfahren
JP2010142237A (ja) * 2000-10-31 2010-07-01 Colgate Palmolive Co 組成物及び方法
US8669282B2 (en) 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
US20020076470A1 (en) * 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
US6555573B2 (en) 2000-12-21 2003-04-29 The Quigley Corporation Method and composition for the topical treatment of diabetic neuropathy
MXPA03007802A (es) * 2001-03-09 2003-12-08 Nestle Sa Composicion que mejora las deficiencias fisiologicas relacionadas con la edad y que incrementa la longevidad.
SE0102380D0 (sv) * 2001-07-02 2001-07-02 Macronova Ab Kräm för behandling av åldersförändringar i huden hos människa
US6923960B2 (en) * 2001-10-03 2005-08-02 Vsl Pharmaceuticals Inc. Antioxidant combination composition and use thereof
EP1455778A4 (de) * 2001-12-19 2007-09-12 The Quigley Corp Verfahren zur behandlung von peripheren nerven- und gefässerkrankungen
US20060127505A1 (en) * 2002-01-16 2006-06-15 David Haines Anti-inflammatory formulations
AU2003219880A1 (en) * 2002-02-22 2003-09-09 Albany College Of Pharmacy Methods and compounds useful in inhibiting oxidative and/or free radical damage and in the treatment and prevention of disease
US20040132821A1 (en) * 2002-10-11 2004-07-08 Roberto Crea Therapeutic combination of carnitine and antioxidant polyphenols
US7083813B2 (en) 2002-11-06 2006-08-01 The Quigley Corporation Methods for the treatment of peripheral neural and vascular ailments
DE10258239A1 (de) * 2002-12-13 2004-06-24 Degussa Ag Formulierung enthaltend alpha-Liponsäure(-Derivate) als alleinigen Wirkstoff bei nichtchronischen alkoholinduzierten Intoxikationen
ITRM20020620A1 (it) * 2002-12-13 2004-06-14 Sigma Tau Ind Farmaceuti Uso delle carnitine per la prevenzione e/o il trattamento dei disturbi causati dall'andropausa.
US20040265345A1 (en) * 2003-06-30 2004-12-30 Perricone Nicholas V. Treatment of skin damage using acetyl carnitine and lipoic acid
US20050214413A1 (en) * 2003-08-26 2005-09-29 Mannatech, Inc. Methods and compositions for modified release of nutritional supplements
US7999003B2 (en) 2003-08-26 2011-08-16 Mannatech, Incorporated Antioxidant compositions and methods thereto
WO2005067972A1 (en) 2003-12-31 2005-07-28 Integrative Health Consulting, Inc. Nutrient compositions and methods for enhanced effectiveness of the immune system
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
US8569367B2 (en) * 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
CN101107012A (zh) * 2004-11-24 2008-01-16 希尔氏宠物营养品公司 改进动物异生素物质肝清除率的方法
US20090176864A1 (en) * 2004-11-24 2009-07-09 Hill's Pet Nutrition, Inc. Methods For Improving Hepatic and Immune Function In An Animal
AU2005309502B2 (en) * 2004-11-24 2011-11-17 Hill's Pet Nutrition, Inc. Methods for increasing the immune response in an animal
AU2005322015B2 (en) 2004-12-29 2010-02-25 Hill's Pet Nutrition, Inc. Methods for inhibiting a decline in learning and/or memory in animals
US8252742B2 (en) * 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
US8148325B2 (en) * 2004-12-30 2012-04-03 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
JP5685362B2 (ja) * 2005-04-26 2015-03-18 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニＳｉｇｍａ−Ｔａｕ Ｉｎｄｕｓｔｒｉｅ Ｆａｒｍａｃｅｕｔｉｃｈｅ Ｒｉｕｎｉｔｅ Ｓｏｃｉｅｔａ Ｐｅｒ Ａｚｉｏｎｉ 有痛性末梢糖尿病性神経障害の予防のためのアセチルｌ−カルニチン
EP1906912B1 (de) 2005-07-14 2012-08-15 Hill's Pet Nutrition, Inc. Verfahren zur verlängerung des lebens von tieren
CA2664982C (en) * 2006-02-23 2015-12-29 Nou-Life Sciences, Inc. Cleavable carnitine compound
CN101045048B (zh) * 2006-03-27 2011-05-18 中国科学院上海生命科学研究院 线粒体营养素组合物的应用
CN101057857B (zh) * 2006-04-21 2011-05-18 中国科学院上海生命科学研究院 一种预防与改善帕金森氏症的组合物及其制法
KR100811110B1 (ko) * 2007-02-21 2008-03-06 주식회사 디피아이 솔루션스 수분산성 α-리포산 캡슐 조성물을 함유하는 어류의 면역력증강용 사료첨가제 및 그 사용방법.
US20080226696A1 (en) * 2007-03-15 2008-09-18 Ben Treadwell Methods of improving learning abilities of aged companion animals
KR20090014568A (ko) * 2007-08-06 2009-02-11 (주)바이오제닉스 코팅된 알파리포산 입자, 이를 포함하는 조성물 및 그 제조방법
US20100255109A1 (en) * 2007-08-06 2010-10-07 Biogenics, Inc. Stabilized antioxidant particles, composition comprising the same and method for preparing the same
US20090054513A1 (en) * 2007-08-22 2009-02-26 Response Scientific, Inc. Method of managing blood glucose levels, insulin levels and/or insulin receptor functionality in individuals with diabetes, polycystic ovarian syndrome and/or alzheimer's disease
US7943163B2 (en) 2007-08-22 2011-05-17 Response Scientific, Inc. Medical food or nutritional supplement, method of manufacturing same, and method of managing diabetes
KR100903549B1 (ko) * 2008-07-29 2009-06-23 주식회사 카이로제닉스 균질한 결정성의 아세틸-ｌ-카르니틴과 티옥트산 칼륨염의 복합염, 이의 제조방법 및 이를 포함하는 약학적 조성물
MX2011004666A (es) * 2008-11-11 2011-05-31 Sigma Tau Ind Farmaceuti Compuesto util para tratar celulitis.
EP2389931A1 (de) * 2010-05-21 2011-11-30 Raw Materials Internatinal LLC Wässrige pharmazeutische Zusammensetzungen mit Liponsäure als Antioxidationsmittel
US9040082B2 (en) 2011-06-24 2015-05-26 K-Pax Pharmaceuticals, Inc. Compositions and methods for treatment of chronic fatigue
US8957048B2 (en) 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
SG11201403013VA (en) 2011-12-07 2014-07-30 Allergan Inc Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
US20140371280A1 (en) * 2013-03-15 2014-12-18 Shinichi Okuyama Method of treating diabetic peripheral neuropathy through amendment of pre-neuronal diabetic coagulative micro-angiopathy and neuronal deficiency of mitochondrial ATP production, and through induction of neuronal regeneration
US20190290609A1 (en) * 2014-03-19 2019-09-26 Epitech Group S.P.A. Pharmaceutical composition comprising palmitoylethanolamide and l-acetylcarnitine
CA2965671A1 (en) 2014-10-24 2016-04-28 Robert Shorr Methods and compositions for the treatment of pre-diabetes, diabetes and metabolic syndrome
UA121399C2 (uk) 2014-11-25 2020-05-25 Аллерган, Інк. Стабілізовані композиції для офтальмологічного застосування, які містять омега-3-кислоти
EP3277273B1 (de) * 2015-03-31 2020-02-26 Kolinpharma S.p.A. Zusammensetzungen zur behandlung von neuropathien und/oder neuropathischen schmerzen
JP6918782B2 (ja) * 2015-08-24 2021-08-11 ヴィトロライフ スウェーデン アクチボラゲット 培養培地
WO2020053754A1 (en) * 2018-09-10 2020-03-19 Uriach Italia S.R.L. Composition comprising lipoic acid and vitamin d for the prevention and the treatment of neurodegenerative diseases and peripheral neuropathies
CN111467385B (zh) * 2019-01-24 2022-05-17 深圳市华大农业应用研究院 组合物在预防或治疗神经退行性疾病中的用途
CN113645854A (zh) * 2019-04-18 2021-11-12 西莫·拉西 预防或减少氧化应激和神经变性疾病的组合物
WO2022215085A1 (en) * 2021-04-06 2022-10-13 Celagenex Research (India) Pvt. Ltd. A synergistic composition for potentiating stabilized atp
CN112999220B (zh) * 2021-04-07 2022-12-13 中国人民解放军南部战区总医院 α-硫辛酸在作为和/或制备金属β-内酰胺酶抑制剂中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668117A (en) * 1991-02-22 1997-09-16 Shapiro; Howard K. Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
WO1997002041A1 (en) * 1995-07-03 1997-01-23 Crandall Wilson T Transdermal and oral treatment of androgenic alopecia
IT1283967B1 (it) 1996-03-29 1998-05-07 Sigma Tau Ind Farmaceuti Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi
US5977162A (en) * 1996-09-16 1999-11-02 Seidman; Michael D. Therapeutic treatment for auditory function
CA2280093A1 (en) * 1997-02-04 1998-08-06 John V. Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases
IT1291113B1 (it) 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US5916912A (en) * 1997-06-16 1999-06-29 The Regents Of The University Of California Dietary composition for enhancing metabolism and alleviating oxidative stress

Also Published As

Publication number Publication date
EP1112005B2 (de) 2010-03-24
US6365622B1 (en) 2002-04-02
DK1112005T3 (da) 2002-12-30
CA2341973A1 (en) 2000-03-09
EP1112005A1 (de) 2001-07-04
ES2188214T3 (es) 2003-06-16
PT1112005E (pt) 2003-03-31
NO20010954D0 (no) 2001-02-26
JP2002523435A (ja) 2002-07-30
TNSN99163A1 (fr) 2005-11-10
KR20010079699A (ko) 2001-08-22
TR200100610T2 (tr) 2001-07-23
JP4361215B2 (ja) 2009-11-11
IL141435A0 (en) 2002-03-10
ITRM980566A1 (it) 2000-03-01
PL346318A1 (en) 2002-01-28
HK1039730A1 (zh) 2002-05-10
AR022076A1 (es) 2002-09-04
NO20010954L (no) 2001-04-25
MA25284A1 (fr) 2001-12-31
IT1302307B1 (it) 2000-09-05
DE69904208D1 (de) 2003-01-09
CN1315835A (zh) 2001-10-03
CA2341973C (en) 2009-05-12
ITRM980566A0 (it) 1998-09-01
EE200100113A (et) 2002-06-17
ES2188214T5 (es) 2010-06-08
HU229165B1 (en) 2013-09-30
AU773424B2 (en) 2004-05-27
DK1112005T4 (da) 2010-06-14
AU5387199A (en) 2000-03-21
WO2000011968A1 (en) 2000-03-09
SK2632001A3 (en) 2001-08-06
HUP0102909A2 (hu) 2002-03-28
IS5850A (is) 2001-02-16
BR9913288A (pt) 2001-05-22
WO2000011968A8 (en) 2000-05-11
EP1112005B1 (de) 2002-11-27
PL212737B1 (pl) 2012-11-30
DE69904208T3 (de) 2010-09-30
DE69904208T2 (de) 2003-08-28
HUP0102909A3 (en) 2002-12-28
CZ2001541A3 (cs) 2001-09-12

Similar Documents

Publication Publication Date Title
ATE228312T1 (de) Antioxidative mischung bestehend aus acetyl l- carnitin und alpha-liponsäure
HUP0100819A3 (en) Aminophenoxyacetic acid derivatives as neuroprotectants and pharmaceutical compositions containing them
DE69918233D1 (de) Polymilchsäure zusammensetzung und daraus hergestellter film
DE69904820D1 (de) Herstellung von kollektorzusammensetzungen aus mischungen von hydroxamfettsäuren und öl zur erzflotation
ITMI950529A0 (it) Composizioni farmaceutiche e procedimento per la loro preparazione
LV12624A (lv) Thienylazolylalcoxyethanamines their preparation and their application as medicaments
ATE392464T1 (de) Zusammensetzungen enthaltend verzweigte primäre alkohole und deren derivate
DE60017392D1 (de) Avenanthramides aus haferextrakt enthaltende zusammensetzungen
HUP0103008A3 (en) Phenoxyacetic acid derivatives and medicinal compositions containing the same
NO984878D0 (no) Fremstilling og anvendelse som medikamenter av 3-alkoksypyridin-2-karboksylsyreamidestere
NO20012265D0 (no) Dispergerbare blandinger inneholdende L-DOPA-etylester
EP1311477A4 (de) Neue thiocarbamidsäurederivate und diese enthaltende arzneimittelgemische
HUP0302635A3 (en) Phospholipid derivatives of valproic acid and mixtures thereof
ATE212225T1 (de) Injizierbare arzneizubereitung bestehend aus paracetamol
PT1087660E (pt) Formulacoes para repelir vermina
EP1220612A4 (de) Pedikulizide und veterinärmedizinische zusammensetzungen
HUP0401572A3 (en) Alpha-ketoglutarates of l-carnitine and compositions containing same
DE60110970D1 (de) Herstellung von gemischten Säureanhydriden und Amidverbindungen
DE69902427D1 (de) Hetero-ethynyl-verbindungen und diese enthaltende zusammensetzungen und kosmetika
DE69906633D1 (de) Mischung bestehend aus ein Retinoid und eine Histidinederivate
IL138994A0 (en) 2-methylpropionic acid derivatives and medicinal compositions containing the same
DE60139151D1 (de) Haarwuchshemmer und diese enthaltende zusammensetzungen
ITMI951417A0 (it) Composizioni farmaceutiche e procedimento per la loro preparazione
ITMI950961A0 (it) Composizioni farmaceutiche contenenti gemfibrozil
HUP0102705A3 (en) Alpha-amino acid phenyl ester derivatives and their use and pharmaceutical compositions comprising them

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1112005

Country of ref document: EP

UEP Publication of translation of european patent specification

Ref document number: 1112005

Country of ref document: EP